Jonathan Sherlock
- Immunology top 0.5%
- Psoriasis: Treatment and Pathogenesis 13
- Mast cells and histamine 1
- Rheumatology top 0.5%
- Spondyloarthritis Studies and Treatments 8
- Systemic Lupus Erythematosus Research 2
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 6
- Dermatology top 1%
- Dermatology and Skin Diseases 7
-
- Inflammasome and immune disorders 2
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
- Co-authors
- J. DanielRobert A. KasteleinDaniel M. GormanWayne ToMaria WiekowskiTatyana ChurakovaBrian W. P. SeymourSérgio A. Lira
- Cited by
- ImmunologyRheumatologyHematology
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Jonathan Sherlock
16 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Immunology 2.8k
- Rheumatology 1.1k
- Hematology 615
- Dermatology 410
- Pathology and Forensic Medicine 494
Countries citing papers authored by Jonathan Sherlock
This map shows the geographic impact of Jonathan Sherlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Sherlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Sherlock more than expected).
Fields of papers citing papers by Jonathan Sherlock
This network shows the impact of papers produced by Jonathan Sherlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Sherlock. The network helps show where Jonathan Sherlock may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan Sherlock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapybreakdown → | 2024 | 42 |
| 6 | 2021 | 14 | |
| 7 | 2020 | 66 | |
| 8 | 2019 | 160 | |
| 9 | 2018 | 79 | |
| 10 | 2015 | 12 | |
| 11 | 2014 | 24 | |
| 12 | 2013 | 8 | |
| 13 | 2013 | 41 | |
| 14 | 2013 | 0 | |
| 15 | 2013 | 5 | |
| 16 | IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cellsbreakdown → | 2012 | 791 |
| 17 | 2011 | 32 | |
| 18 | 2010 | 35 | |
| 19 | 2009 | 11 | |
| 20 | Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainbreakdown → | 2003 | 2297 |
About Jonathan Sherlock
Jonathan Sherlock is a scholar working on Dermatology, Rheumatology, Immunology, Hematology and Biological Psychiatry, having authored 20 papers that have together received 3.6k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (13 papers), Spondyloarthritis Studies and Treatments (8 papers), Dermatology and Skin Diseases (7 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Systemic Lupus Erythematosus Research (2 papers), Inflammasome and immune disorders (2 papers), Mast cells and histamine (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Immunology (2.8k citations), Rheumatology (1.1k citations), Hematology (615 citations), Dermatology (410 citations) and Pathology and Forensic Medicine (494 citations). Jonathan Sherlock has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include J. Daniel, Robert A. Kastelein, Daniel M. Gorman, Wayne To, Maria Wiekowski, Tatyana Churakova, Brian W. P. Seymour, Sérgio A. Lira, Sandra Zurawski and Jonathon D. Sedgwick. Their work appears in journals such as Nature Medicine, The Lancet, FEBS Letters, Annals of the Rheumatic Diseases and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.